tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MIRA Stock Latest News

Psychedelic: Analyst initiates Definium, Helus with Buy ratings
The FlyPsychedelic: Analyst initiates Definium, Helus with Buy ratings
26d ago
CMND
DFTX
Mira Pharmaceuticals initiates final cohort of Ketamir-2 Phase 1 study
PremiumThe Fly
Mira Pharmaceuticals initiates final cohort of Ketamir-2 Phase 1 study
28d ago
MIRA
MIRA Pharmaceuticals Advances Ketamir-2 Phase 1 to Final Cohort
PremiumCompany Announcements
MIRA Pharmaceuticals Advances Ketamir-2 Phase 1 to Final Cohort
29d ago
8K
MIRA
Mira Pharmaceuticals initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Mira Pharmaceuticals initiated with a Buy at Rodman & Renshaw
2M ago
MIRA
MIRA Pharmaceuticals Expands Stock Offering by $15M
PremiumCompany Announcements
MIRA Pharmaceuticals Expands Stock Offering by $15M
3M ago
8K
MIRA
Psychedelic: Compass Pathways, NeuroKaire enter R&D collaboration
PremiumThe FlyPsychedelic: Compass Pathways, NeuroKaire enter R&D collaboration
4M ago
ATAI
CMND
Mira Pharmaceuticals initiates MAD Phase 1 study of oral ketamir-2
Premium
The Fly
Mira Pharmaceuticals initiates MAD Phase 1 study of oral ketamir-2
4M ago
MIRA
MIRA Pharmaceuticals Advances Ketamir-2 Clinical Trials
Premium
Company Announcements
MIRA Pharmaceuticals Advances Ketamir-2 Clinical Trials
4M ago
8K
MIRA
MIRA Pharmaceuticals Sells Shares at 66% Premium
PremiumCompany Announcements
MIRA Pharmaceuticals Sells Shares at 66% Premium
5M ago
8K
MIRA
Mira Pharmaceuticals announces preclinical data on oral Mira-55
PremiumThe Fly
Mira Pharmaceuticals announces preclinical data on oral Mira-55
5M ago
MIRA
MIRA Pharmaceuticals’ Mira-55 Outperforms Morphine in Study
PremiumCompany Announcements
MIRA Pharmaceuticals’ Mira-55 Outperforms Morphine in Study
5M ago
8K
MIRA
Mira Pharmaceuticals closes acquisition of SKNY Pharmaceuticals
PremiumThe Fly
Mira Pharmaceuticals closes acquisition of SKNY Pharmaceuticals
5M ago
MIRA
MIRA Pharmaceuticals Completes SKNY Acquisition
PremiumCompany AnnouncementsMIRA Pharmaceuticals Completes SKNY Acquisition
5M ago
8K
MIRA
Mira Pharmaceuticals announces topline results from Phase 1 SAD study
Premium
The Fly
Mira Pharmaceuticals announces topline results from Phase 1 SAD study
5M ago
MIRA
MIRA Pharmaceuticals Reports Positive Phase 1 Study Results
Premium
Company Announcements
MIRA Pharmaceuticals Reports Positive Phase 1 Study Results
5M ago
8K
MIRA
Mira Pharmaceuticals reports Ketamir-2 data in PTSD
PremiumThe Fly
Mira Pharmaceuticals reports Ketamir-2 data in PTSD
6M ago
MIRA
MIRA Pharmaceuticals Reports Positive Ketamir-2 Study Results
PremiumCompany Announcements
MIRA Pharmaceuticals Reports Positive Ketamir-2 Study Results
6M ago
8K
MIRA
Mira Pharmaceuticals shareholders approve acquisition of SKNY Pharmaceuticals
PremiumThe Fly
Mira Pharmaceuticals shareholders approve acquisition of SKNY Pharmaceuticals
6M ago
MIRA
MIRA Pharmaceuticals Approves 2022 Omnibus Incentive Plan
PremiumCompany Announcements
MIRA Pharmaceuticals Approves 2022 Omnibus Incentive Plan
6M ago
8K
MIRA
Psychedelic: NRx Pharmaceuticals reports Q2 earnings
PremiumThe FlyPsychedelic: NRx Pharmaceuticals reports Q2 earnings
6M ago
MIRA
NRXP
Mira Pharmaceuticals completes Phase 1 SAD portion for oral Ketamir-2
Premium
The Fly
Mira Pharmaceuticals completes Phase 1 SAD portion for oral Ketamir-2
7M ago
MIRA
MIRA Pharmaceuticals Completes Phase 1 Trial for Ketamir-2
Premium
Company Announcements
MIRA Pharmaceuticals Completes Phase 1 Trial for Ketamir-2
7M ago
8K
MIRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >